Category: us corporate news

us corporate news

Canton Strategic Holdings CEO Mark Wendland Elected to Canton Foundation Board, Advancing Institutional Blockchain Adoption 1

Minichart

March 3, 2026

Canton Strategic Holdings CEO Joins Canton Foundation Board:...

Continue Reading 0

us corporate news

Adial Pharmaceuticals Signs $60M Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for European Commercialization

Minichart

March 3, 2026

Adial Pharmaceuticals Signs Exclusive AD04 Collaboration Fra...

Continue Reading 0

us corporate news

NB Bancorp, Inc. (NBBK) 2025 Annual Report: Financials, Investments, Loan Portfolio, and Equity Method Investments Overview

Minichart

March 3, 2026

NB Bancorp, Inc. 2025 Annual Report: Key Investor Insights ...

Continue Reading 0

us corporate news

Heartland Express, Inc. 2025 Annual Report: Business Overview, Risk Factors, Environmental Compliance, and Financial Performance 14373854

Minichart

March 3, 2026

Executive Summary Heartland Express, Inc. (NASDAQ: HTLD...

Continue Reading 0

us corporate news

Real Asset Acquisition Corp. 2026 Annual Report – Business Combination, Risk Factors, and SPAC Updates

Minichart

March 3, 2026

Real Asset Acquisition Corp. Annual Report - Key Highlights ...

Continue Reading 0

us corporate news

Digital Asset Acquisition Corp. (DAAQU) 2025 Annual Report: Business Strategy, Risks, and Shareholder Information (Form 10-K)

Minichart

March 3, 2026

Digital Asset Acquisition Corp. 2025 Annual Report – Key Hig...

Continue Reading 0

us corporate news

Anika Therapeutics, Inc. 2025 Annual Report: Business Overview, Strategy, Product Portfolio, and Regulatory Compliance

Minichart

March 3, 2026

Anika Therapeutics, Inc. 2025 Annual Report: Key Highlights ...

Continue Reading 0

us corporate news

Hycroft Mining Holding Corporation 2025 Annual Report: Business Overview, Risk Factors, Executive Team, and Financial Highlights

Minichart

March 3, 2026

Hycroft Mining Holding Corporation (HYMC) 2025 Annual Report...

Continue Reading 0

us corporate news

Amylyx Pharmaceuticals 2025 Annual Report: Clinical Pipeline, Business Overview, Regulatory, and Intellectual Property Insights

Minichart

March 3, 2026

Amylyx Pharmaceuticals, Inc. 2025 Annual Report: Key Highlig...

Continue Reading 0

us corporate news

Passage Bio, Inc. 2025 Annual Report: Business Overview, Risk Factors, Clinical Pipeline, and Regulatory Insights

Minichart

March 3, 2026

Passage Bio, Inc. 2025 Annual Report – Key Investor Highligh...

Continue Reading 0